tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ahu Demir, 7 are a BUY (87.5%), 1 are a HOLD (12.5%).
Analyst Ahu Demir, currently employed at LADENBURG, carries an average stock price target met ratio of 50% that have a potential upside of 17.89% achieved within 65 days. Previously, Ahu Demir worked at NOBLE CAPITAL.
Ahu Demir’s has documented 14 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EVAX, Evaxion Biotech AS at 02-Apr-2024.
Analyst best performing recommendations are on ONTX (ONCONOVA THERAPEUTICS).
The best stock recommendation documented was for ONTX (ONCONOVA THERAPEUTICS) at 12/22/2020. The price target of $6.9 was fulfilled within 1 day with a profit of $0.47 (7.31%) receiving and performance score of 73.09.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$16
2 years 5 months 27 days ago
(31-Oct-2022)
0/1 (0%)
$12 (300.00%)
Buy
$1
$0.4 (66.67%)
$20
2 years 6 months 7 days ago
(20-Oct-2022)
1/2 (50%)
$4.66 (64.44%)
67
Buy
2 years 8 months 11 days ago
(16-Aug-2022)
0/1 (0%)
$9.16 (103.62%)
Buy
$6
$5.5 (1100.00%)
$24
3 years 28 days ago
(30-Mar-2022)
0/2 (0%)
$2 (50.00%)
Buy
$12
$11.5 (2300.00%)
$22
3 years 28 days ago
(30-Mar-2022)
0/2 (0%)
$8 (200.00%)
What Year was the first public recommendation made by Ahu Demir?
